Responsible use of cephalosporins experience and observations - - PowerPoint PPT Presentation

responsible use of cephalosporins experience and
SMART_READER_LITE
LIVE PREVIEW

Responsible use of cephalosporins experience and observations - - PowerPoint PPT Presentation

Responsible use of cephalosporins experience and observations Valrie Thom as I FAH-Europe Statem ent IFAH Europe fully supports the global frame of responsible use notably for modern antibiotics Overall industry made very positive


slide-1
SLIDE 1

Responsible use of cephalosporins experience and observations

Valérie Thom as I FAH-Europe

slide-2
SLIDE 2

Statem ent

  • IFAH Europe fully supports the global frame of

responsible use notably for modern antibiotics

  • Overall industry made very positive experience

with the implementation of responsible use for modern antibiotics e.g. cephalosporins

slide-3
SLIDE 3

Experience/ value of responsible use m easures

– Prescription only + + – Parenteral & individual treatm. + + + – SmPC recommendations + + + – Susceptibility testing + + + – Surveillance + + + – Reserve antibiotics

  • – Restricted indications

(+ )

slide-4
SLIDE 4

Volum es used of m odern cephalosporins

Modern cephalosporins account for less than 1% of the total use of antibiotics in (kg) in pets and food producing animals (Maran, Danmap, Afssa) The very low extent of use is a result of responsible use guidelines and the SmPC recommendations

slide-5
SLIDE 5

Susceptibility Surveillance

  • High quality surveillance data are a prerequisite to control

and manage antimicrobial resistance

  • The quality of surveillance data has been increased over the
  • years. All license holders must participate in a pan-European

program.

  • The low rate of resistance to modern cephalosporins is a

direct result of the responsible use measures

slide-6
SLIDE 6

I neffective responsible use m easures

  • Reserve antibiotics

– Older compounds to select for resistance – Emergence of population with pre-selected antibiotic co- and cross-resistance

  • Limitations of indications

– Has no measurable effect when volumes of use are already very low – Therapeutic range of available medicines should not be excessively limited

slide-7
SLIDE 7

Conclusions

  • Responsible use of modern antibiotics is necessary and

there are very effective measures in place to contain antimicrobial resistance

  • Susceptibility surveillance programs must be further

developed

  • Research is required to better understand resistance

before putting new measures into place

slide-8
SLIDE 8

Thank you for your attention